Women's Health, Hormonal Therapies
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
110
NCT00497458
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2007
Completion: Jun 30, 2009
NCT03264651
Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density
Phase: Phase 1
Start: Feb 1, 2017
Completion: Mar 21, 2018
NCT03314298
A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole
Start: Aug 14, 2017
Completion: Apr 17, 2018
Loading map...